Global Orally Disintegrating Tablet Excipient Market Growth 2020-2025
According to this study, over the next five years the Orally Disintegrating Tablet Excipient market will register a 3.6%% CAGR in terms of revenue, the global market size will reach $ 17740 million by 2025, from $ 15380 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Orally Disintegrating Tablet Excipient business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet Excipient market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Orally Disintegrating Tablet Excipient, covering the supply chain analysis, impact assessment to the Orally Disintegrating Tablet Excipient market size growth rate in several scenarios, and the measures to be undertaken by Orally Disintegrating Tablet Excipient companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Binders
Glidents
Diluents
Disintegrants
Others
Binders had the biggest market share of 37% in 2018.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BASF
Shin-Etsu
JRS Pharma
ABF Ingredients
DFE Pharma
Roquette
Ashland
Evonik
Meggle Pharma
Merck KGaA
Fuji Chemical Industries
Daicel Corporation
Cargill Incorporated
Anhui Sunhere Pharmaceutical
McePharma (Vivesa holding)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Orally Disintegrating Tablet Excipient consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Orally Disintegrating Tablet Excipient market by identifying its various subsegments.
Focuses on the key global Orally Disintegrating Tablet Excipient manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Orally Disintegrating Tablet Excipient with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Orally Disintegrating Tablet Excipient submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orally Disintegrating Tablet Excipient Consumption 2015-2025
2.1.2 Orally Disintegrating Tablet Excipient Consumption CAGR by Region
2.2 Orally Disintegrating Tablet Excipient Segment by Type
2.2.1 Binders
2.2.2 Glidents
2.2.3 Diluents
2.2.4 Disintegrants
2.2.5 Others
2.3 Orally Disintegrating Tablet Excipient Consumption by Type
2.3.1 Global Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
2.3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2015-2020)
2.3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Type (2015-2020)
2.4 Orally Disintegrating Tablet Excipient Segment by Application
2.4.1 Anti-Psychotics Drug
2.4.2 Anti-Epileptics Drug
2.4.3 Others
2.5 Orally Disintegrating Tablet Excipient Consumption by Application
2.5.1 Global Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
2.5.2 Global Orally Disintegrating Tablet Excipient Value and Market Share by Type (2015-2020)
2.5.3 Global Orally Disintegrating Tablet Excipient Sale Price by Type (2015-2020)
3 Global Orally Disintegrating Tablet Excipient by Company
3.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company
3.1.1 Global Orally Disintegrating Tablet Excipient Sales by Company (2018-2020)
3.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2018-2020)
3.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company
3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Company (2018-2020)
3.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2018-2020)
3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Company
3.4 Global Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Orally Disintegrating Tablet Excipient Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Orally Disintegrating Tablet Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Orally Disintegrating Tablet Excipient by Regions
4.1 Orally Disintegrating Tablet Excipient by Regions
4.2 Americas Orally Disintegrating Tablet Excipient Consumption Growth
4.3 APAC Orally Disintegrating Tablet Excipient Consumption Growth
4.4 Europe Orally Disintegrating Tablet Excipient Consumption Growth
4.5 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Growth
5 Americas
5.1 Americas Orally Disintegrating Tablet Excipient Consumption by Countries
5.1.1 Americas Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020)
5.1.2 Americas Orally Disintegrating Tablet Excipient Value by Countries (2015-2020)
5.2 Americas Orally Disintegrating Tablet Excipient Consumption by Type
5.3 Americas Orally Disintegrating Tablet Excipient Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Orally Disintegrating Tablet Excipient Consumption by Regions
6.1.1 APAC Orally Disintegrating Tablet Excipient Consumption by Regions (2015-2020)
6.1.2 APAC Orally Disintegrating Tablet Excipient Value by Regions (2015-2020)
6.2 APAC Orally Disintegrating Tablet Excipient Consumption by Type
6.3 APAC Orally Disintegrating Tablet Excipient Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Orally Disintegrating Tablet Excipient by Countries
7.1.1 Europe Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020)
7.1.2 Europe Orally Disintegrating Tablet Excipient Value by Countries (2015-2020)
7.2 Europe Orally Disintegrating Tablet Excipient Consumption by Type
7.3 Europe Orally Disintegrating Tablet Excipient Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Orally Disintegrating Tablet Excipient by Countries
8.1.1 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Orally Disintegrating Tablet Excipient Value by Countries (2015-2020)
8.2 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption by Type
8.3 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Orally Disintegrating Tablet Excipient Distributors
10.3 Orally Disintegrating Tablet Excipient Customer
11 Global Orally Disintegrating Tablet Excipient Market Forecast
11.1 Global Orally Disintegrating Tablet Excipient Consumption Forecast (2021-2025)
11.2 Global Orally Disintegrating Tablet Excipient Forecast by Regions
11.2.1 Global Orally Disintegrating Tablet Excipient Forecast by Regions (2021-2025)
11.2.2 Global Orally Disintegrating Tablet Excipient Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Orally Disintegrating Tablet Excipient Forecast by Type
11.8 Global Orally Disintegrating Tablet Excipient Forecast by Application
12 Key Players Analysis
12.1 BASF
12.1.1 Company Information
12.1.2 Orally Disintegrating Tablet Excipient Product Offered
12.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 BASF Latest Developments
12.2 Shin-Etsu
12.2.1 Company Information
12.2.2 Orally Disintegrating Tablet Excipient Product Offered
12.2.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shin-Etsu Latest Developments
12.3 JRS Pharma
12.3.1 Company Information
12.3.2 Orally Disintegrating Tablet Excipient Product Offered
12.3.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 JRS Pharma Latest Developments
12.4 ABF Ingredients
12.4.1 Company Information
12.4.2 Orally Disintegrating Tablet Excipient Product Offered
12.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ABF Ingredients Latest Developments
12.5 DFE Pharma
12.5.1 Company Information
12.5.2 Orally Disintegrating Tablet Excipient Product Offered
12.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 DFE Pharma Latest Developments
12.6 Roquette
12.6.1 Company Information
12.6.2 Orally Disintegrating Tablet Excipient Product Offered
12.6.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Roquette Latest Developments
12.7 Ashland
12.7.1 Company Information
12.7.2 Orally Disintegrating Tablet Excipient Product Offered
12.7.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Ashland Latest Developments
12.8 Evonik
12.8.1 Company Information
12.8.2 Orally Disintegrating Tablet Excipient Product Offered
12.8.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Evonik Latest Developments
12.9 Meggle Pharma
12.9.1 Company Information
12.9.2 Orally Disintegrating Tablet Excipient Product Offered
12.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Meggle Pharma Latest Developments
12.10 Merck KGaA
12.10.1 Company Information
12.10.2 Orally Disintegrating Tablet Excipient Product Offered
12.10.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Merck KGaA Latest Developments
12.11 Fuji Chemical Industries
12.11.1 Company Information
12.11.2 Orally Disintegrating Tablet Excipient Product Offered
12.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Fuji Chemical Industries Latest Developments
12.12 Daicel Corporation
12.12.1 Company Information
12.12.2 Orally Disintegrating Tablet Excipient Product Offered
12.12.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Daicel Corporation Latest Developments
12.13 Cargill Incorporated
12.13.1 Company Information
12.13.2 Orally Disintegrating Tablet Excipient Product Offered
12.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Cargill Incorporated Latest Developments
12.14 Anhui Sunhere Pharmaceutical
12.14.1 Company Information
12.14.2 Orally Disintegrating Tablet Excipient Product Offered
12.14.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Anhui Sunhere Pharmaceutical Latest Developments
12.15 McePharma (Vivesa holding)
12.15.1 Company Information
12.15.2 Orally Disintegrating Tablet Excipient Product Offered
12.15.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 McePharma (Vivesa holding) Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Orally Disintegrating Tablet Excipient Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Binders
Table 5. Major Players of Glidents
Table 6. Major Players of Diluents
Table 7. Major Players of Disintegrants
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
Table 11. Global Orally Disintegrating Tablet Excipient Revenue by Type (2015-2020) ($ million)
Table 12. Global Orally Disintegrating Tablet Excipient Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Orally Disintegrating Tablet Excipient Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Application (2015-2020)
Table 16. Global Orally Disintegrating Tablet Excipient Value by Application (2015-2020)
Table 17. Global Orally Disintegrating Tablet Excipient Value Market Share by Application (2015-2020)
Table 18. Global Orally Disintegrating Tablet Excipient Sale Price by Application (2015-2020)
Table 19. Global Orally Disintegrating Tablet Excipient Sales by Company (2017-2019) (K MT)
Table 20. Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2017-2019)
Table 21. Global Orally Disintegrating Tablet Excipient Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2017-2019)
Table 23. Global Orally Disintegrating Tablet Excipient Sale Price by Company (2017-2019)
Table 24. Global Orally Disintegrating Tablet Excipient Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Orally Disintegrating Tablet Excipient Products Offered
Table 26. Orally Disintegrating Tablet Excipient Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Orally Disintegrating Tablet Excipient Consumption by Regions 2015-2020 (K MT)
Table 28. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Regions 2015-2020
Table 29. Global Orally Disintegrating Tablet Excipient Value by Regions 2015-2020 ($ Millions)
Table 30. Global Orally Disintegrating Tablet Excipient Value Market Share by Regions 2015-2020
Table 31. Americas Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020) (K MT)
Table 32. Americas Orally Disintegrating Tablet Excipient Consumption Market Share by Countries (2015-2020)
Table 33. Americas Orally Disintegrating Tablet Excipient Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Orally Disintegrating Tablet Excipient Value Market Share by Countries (2015-2020)
Table 35. Americas Orally Disintegrating Tablet Excipient Consumption by Type (2015-2020) (K MT)
Table 36. Americas Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
Table 37. Americas Orally Disintegrating Tablet Excipient Consumption by Application (2015-2020) (K MT)
Table 38. Americas Orally Disintegrating Tablet Excipient Consumption Market Share by Application (2015-2020)
Table 39. APAC Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020) (K MT)
Table 40. APAC Orally Disintegrating Tablet Excipient Consumption Market Share by Countries (2015-2020)
Table 41. APAC Orally Disintegrating Tablet Excipient Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Orally Disintegrating Tablet Excipient Value Market Share by Regions (2015-2020)
Table 43. APAC Orally Disintegrating Tablet Excipient Consumption by Type (2015-2020) (K MT)
Table 44. APAC Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
Table 45. APAC Orally Disintegrating Tablet Excipient Consumption by Application (2015-2020) (K MT)
Table 46. APAC Orally Disintegrating Tablet Excipient Consumption Market Share by Application (2015-2020)
Table 47. Europe Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020) (K MT)
Table 48. Europe Orally Disintegrating Tablet Excipient Consumption Market Share by Countries (2015-2020)
Table 49. Europe Orally Disintegrating Tablet Excipient Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Orally Disintegrating Tablet Excipient Value Market Share by Countries (2015-2020)
Table 51. Europe Orally Disintegrating Tablet Excipient Consumption by Type (2015-2020) (K MT)
Table 52. Europe Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
Table 53. Europe Orally Disintegrating Tablet Excipient Consumption by Application (2015-2020) (K MT)
Table 54. Europe Orally Disintegrating Tablet Excipient Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption by Countries (2015-2020) (K MT)
Table 56. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Orally Disintegrating Tablet Excipient Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Orally Disintegrating Tablet Excipient Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption by Type (2015-2020) (K MT)
Table 60. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption by Application (2015-2020) (K MT)
Table 62. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Market Share by Application (2015-2020)
Table 63. Orally Disintegrating Tablet Excipient Distributors List
Table 64. Orally Disintegrating Tablet Excipient Customer List
Table 65. Global Orally Disintegrating Tablet Excipient Consumption Forecast by Countries (2021-2025) (K MT)
Table 66. Global Orally Disintegrating Tablet Excipient Consumption Market Forecast by Regions
Table 67. Global Orally Disintegrating Tablet Excipient Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Orally Disintegrating Tablet Excipient Value Market Share Forecast by Regions
Table 69. Global Orally Disintegrating Tablet Excipient Consumption Forecast by Type (2021-2025) (K MT)
Table 70. Global Orally Disintegrating Tablet Excipient Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Orally Disintegrating Tablet Excipient Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Orally Disintegrating Tablet Excipient Value Market Share Forecast by Type (2021-2025)
Table 73. Global Orally Disintegrating Tablet Excipient Consumption Forecast by Application (2021-2025) (K MT)
Table 74. Global Orally Disintegrating Tablet Excipient Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Orally Disintegrating Tablet Excipient Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Orally Disintegrating Tablet Excipient Value Market Share Forecast by Application (2021-2025)
Table 77. BASF Product Offered
Table 78. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 79. BASF Main Business
Table 80. BASF Latest Developments
Table 81. BASF Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 82. Shin-Etsu Product Offered
Table 83. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 84. Shin-Etsu Main Business
Table 85. Shin-Etsu Latest Developments
Table 86. Shin-Etsu Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 87. JRS Pharma Product Offered
Table 88. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 89. JRS Pharma Main Business
Table 90. JRS Pharma Latest Developments
Table 91. JRS Pharma Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 92. ABF Ingredients Product Offered
Table 93. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 94. ABF Ingredients Main Business
Table 95. ABF Ingredients Latest Developments
Table 96. ABF Ingredients Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 97. DFE Pharma Product Offered
Table 98. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 99. DFE Pharma Main Business
Table 100. DFE Pharma Latest Developments
Table 101. DFE Pharma Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 102. Roquette Product Offered
Table 103. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 104. Roquette Main Business
Table 105. Roquette Latest Developments
Table 106. Roquette Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 107. Ashland Product Offered
Table 108. Ashland Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 109. Ashland Main Business
Table 110. Ashland Latest Developments
Table 111. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Evonik Product Offered
Table 113. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 114. Evonik Main Business
Table 115. Evonik Latest Developments
Table 116. Evonik Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 117. Meggle Pharma Product Offered
Table 118. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 119. Meggle Pharma Main Business
Table 120. Meggle Pharma Latest Developments
Table 121. Meggle Pharma Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 122. Merck KGaA Product Offered
Table 123. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 124. Merck KGaA Main Business
Table 125. Merck KGaA Latest Developments
Table 126. Merck KGaA Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 127. Fuji Chemical Industries Product Offered
Table 128. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 129. Fuji Chemical Industries Main Business
Table 130. Fuji Chemical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Fuji Chemical Industries Latest Developments
Table 132. Daicel Corporation Product Offered
Table 133. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 134. Daicel Corporation Main Business
Table 135. Daicel Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Daicel Corporation Latest Developments
Table 137. Cargill Incorporated Product Offered
Table 138. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 139. Cargill Incorporated Main Business
Table 140. Cargill Incorporated Latest Developments
Table 141. Cargill Incorporated Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 142. Anhui Sunhere Pharmaceutical Product Offered
Table 143. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 144. Anhui Sunhere Pharmaceutical Main Business
Table 145. Anhui Sunhere Pharmaceutical Latest Developments
Table 146. Anhui Sunhere Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. McePharma (Vivesa holding) Product Offered
Table 148. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 149. McePharma (Vivesa holding) Main Business
Table 150. McePharma (Vivesa holding) Latest Developments
Table 151. McePharma (Vivesa holding) Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Orally Disintegrating Tablet Excipient
Figure 2. Orally Disintegrating Tablet Excipient Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Orally Disintegrating Tablet Excipient Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Orally Disintegrating Tablet Excipient Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Binders
Figure 7. Product Picture of Glidents
Figure 8. Product Picture of Diluents
Figure 9. Product Picture of Disintegrants
Figure 10. Product Picture of Others
Figure 11. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Type (2015-2020)
Figure 12. Global Orally Disintegrating Tablet Excipient Value Market Share by Type (2015-2020)
Figure 13. Orally Disintegrating Tablet Excipient Consumed in Anti-Psychotics Drug
Figure 14. Global Orally Disintegrating Tablet Excipient Market: Anti-Psychotics Drug (2015-2020) (K MT)
Figure 15. Global Orally Disintegrating Tablet Excipient Market: Anti-Psychotics Drug (2015-2020) ($ Millions)
Figure 16. Orally Disintegrating Tablet Excipient Consumed in Anti-Epileptics Drug
Figure 17. Global Orally Disintegrating Tablet Excipient Market: Anti-Epileptics Drug (2015-2020) (K MT)
Figure 18. Global Orally Disintegrating Tablet Excipient Market: Anti-Epileptics Drug (2015-2020) ($ Millions)
Figure 19. Orally Disintegrating Tablet Excipient Consumed in Others
Figure 20. Global Orally Disintegrating Tablet Excipient Market: Others (2015-2020) (K MT)
Figure 21. Global Orally Disintegrating Tablet Excipient Market: Others (2015-2020) ($ Millions)
Figure 22. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Application (2015-2020)
Figure 23. Global Orally Disintegrating Tablet Excipient Value Market Share by Application (2015-2020)
Figure 24. Global Orally Disintegrating Tablet Excipient Sales Market Share by Company in 2017
Figure 25. Global Orally Disintegrating Tablet Excipient Sales Market Share by Company in 2019
Figure 26. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company in 2017
Figure 27. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company in 2019
Figure 28. Global Orally Disintegrating Tablet Excipient Sale Price by Company in 2019
Figure 29. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Regions 2015-2020
Figure 30. Global Orally Disintegrating Tablet Excipient Value Market Share by Regions 2015-2020
Figure 31. Americas Orally Disintegrating Tablet Excipient Consumption 2015-2020 (K MT)
Figure 32. Americas Orally Disintegrating Tablet Excipient Value 2015-2020 ($ Millions)
Figure 33. APAC Orally Disintegrating Tablet Excipient Consumption 2015-2020 (K MT)
Figure 34. APAC Orally Disintegrating Tablet Excipient Value 2015-2020 ($ Millions)
Figure 35. Europe Orally Disintegrating Tablet Excipient Consumption 2015-2020 (K MT)
Figure 36. Europe Orally Disintegrating Tablet Excipient Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption 2015-2020 (K MT)
Figure 38. Middle East & Africa Orally Disintegrating Tablet Excipient Value 2015-2020 ($ Millions)
Figure 39. Americas Orally Disintegrating Tablet Excipient Consumption Market Share by Countries in 2019
Figure 40. Americas Orally Disintegrating Tablet Excipient Value Market Share by Countries in 2019
Figure 41. Americas Orally Disintegrating Tablet Excipient Consumption Market Share by Type in 2019
Figure 42. Americas Orally Disintegrating Tablet Excipient Consumption Market Share by Application in 2019
Figure 43. United States Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 44. United States Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 46. Canada Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 48. Mexico Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Orally Disintegrating Tablet Excipient Consumption Market Share by Countries in 2019
Figure 50. APAC Orally Disintegrating Tablet Excipient Value Market Share by Regions in 2019
Figure 51. APAC Orally Disintegrating Tablet Excipient Consumption Market Share by Type in 2019
Figure 52. APAC Orally Disintegrating Tablet Excipient Consumption Market Share by Application in 2019
Figure 53. China Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 54. China Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 56. Japan Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 58. Korea Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 60. Southeast Asia Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 61. India Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 62. India Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 64. Australia Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Orally Disintegrating Tablet Excipient Consumption Market Share by Countries in 2019
Figure 66. Europe Orally Disintegrating Tablet Excipient Value Market Share by Countries in 2019
Figure 67. Europe Orally Disintegrating Tablet Excipient Consumption Market Share by Type in 2019
Figure 68. Europe Orally Disintegrating Tablet Excipient Consumption Market Share by Application in 2019
Figure 69. Germany Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 70. Germany Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 71. France Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 72. France Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 73. UK Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 74. UK Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 76. Italy Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 78. Russia Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Orally Disintegrating Tablet Excipient Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Market Share by Application in 2019
Figure 83. Egypt Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 84. Egypt Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 86. South Africa Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 88. Israel Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 90. Turkey Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Orally Disintegrating Tablet Excipient Consumption Growth 2015-2020 (K MT)
Figure 92. GCC Countries Orally Disintegrating Tablet Excipient Value Growth 2015-2020 ($ Millions)
Figure 93. Global Orally Disintegrating Tablet Excipient Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 94. Global Orally Disintegrating Tablet Excipient Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 96. Americas Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 97. APAC Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 98. APAC Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 99. Europe Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 100. Europe Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 102. Middle East & Africa Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 103. United States Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 104. United States Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 105. Canada Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 106. Canada Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 107. Mexico Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 108. Mexico Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 109. Brazil Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 110. Brazil Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 111. China Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 112. China Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 113. Japan Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 114. Japan Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 115. Korea Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 116. Korea Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 118. Southeast Asia Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 119. India Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 120. India Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 121. Australia Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 122. Australia Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 123. Germany Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 124. Germany Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 125. France Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 126. France Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 127. UK Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 128. UK Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 129. Italy Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 130. Italy Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 131. Russia Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 132. Russia Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 133. Spain Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 134. Spain Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 135. Egypt Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 136. Egypt Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 137. South Africa Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 138. South Africa Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 139. Israel Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 140. Israel Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 141. Turkey Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 142. Turkey Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Orally Disintegrating Tablet Excipient Consumption 2021-2025 (K MT)
Figure 144. GCC Countries Orally Disintegrating Tablet Excipient Value 2021-2025 ($ Millions)
Figure 145. BASF Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 146. Shin-Etsu Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 147. JRS Pharma Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 148. ABF Ingredients Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 149. DFE Pharma Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 150. Roquette Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 151. Ashland Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 152. Evonik Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 153. Meggle Pharma Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 154. Merck KGaA Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 155. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 156. Daicel Corporation Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 157. Cargill Incorporated Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 158. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Figure 159. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets